NCAB Says President’s Budget Would “Seriously Damage” Cancer Program
In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says
Biology Societies Recomend 15% Funding Increase for NIH
Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says
Letter to The Editor: IOM Panel Urges Greater Integration Of Research
Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?